Rutgeerts, Paul

A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

Targan, S. R., Hanauer, S. B., van Deventer, S. J. H., Mayer, L., Present, D. H., Braakman, T., DeWoody, K. L., Schaible, T. F., & Rutgeerts, P. J. (1997) · New England Journal of Medicine

Inflammatory Bowel DiseaseRheumatoid Arthritis Research and Therapies

Cited by 3,135

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

the NIDDK IBD Genetics Consortium, Barrett, J. C., the Belgian-French IBD Consortium, the Wellcome Trust Case Control Consortium, Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., et al. (2008) · Nature Genetics

Inflammatory Bowel DiseaseGenetic Associations and Epidemiology

Cited by 2,593

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

Franke, A., McGovern, D. P. B., Barrett, J. C., Wang, K., Radford-Smith, G. L., Ahmad, T., Lees, C. W., Balschun, T., Lee, J., Roberts, R., et al. (2010) · Nature Genetics

Inflammatory Bowel DiseaseGenetic Associations and Epidemiology

Cited by 2,520

Histamine Receptor H1–Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome

Wouters, M. M., Balemans, D., Van Wanrooy, S., Dooley, J., Cibert-Goton, V., Alpizar, Y. A., Valdez-Morales, E. E., Nasser, Y., Van Veldhoven, P. P., Vanbrabant, W., et al. (2016) · Gastroenterology

Gastrointestinal motility and disordersIon Channels and Receptors

Cited by 372

Autoimmunity associated with anti-tumor necrosis factor α treatment in Crohn’s disease: a prospective cohort study

Vermeire, S., Noman, M., Van Assche, G., Baert, F., Van Steen, K., Esters, N., Joossens, S., Bossuyt, X., & Rutgeerts, P. (2003) · Gastroenterology

Inflammatory Bowel DiseaseSystemic Lupus Erythematosus Research

Cited by 327

Donor species richness determines faecal microbiota transplantation success in inflammatory bowel disease

Vermeire, S., Joossens, M., Verbeke, K., Wang, J., Machiels, K., Sabino, J., Ferrante, M., Van Assche, G., Rutgeerts, P., & Raes, J. (2016) · Journal of Crohn s and Colitis

Inflammatory Bowel DiseaseGut microbiota and health

Cited by 311

American Gastroenterological Association Consensus Development Conference on the Use of Biologics in the Treatment of Inflammatory Bowel Disease, June 21–23, 2006

Clark, M., Colombel, J.-F., Feagan, B. C., Fedorak, R. N., Hanauer, S. B., Kamm, M. A., Mayer, L., Regueiro, C., Rutgeerts, P., Sandborn, W. J., et al. (2007) · Gastroenterology

Inflammatory Bowel DiseaseRheumatoid Arthritis Research and Therapies

Cited by 224

Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease

Momozawa, Y., Mni, M., Nakamura, K., Coppieters, W., Almer, S., Amininejad, L., Cleynen, I., Colombel, J.-F., de Rijk, P., Dewit, O., et al. (2011) · Nature Genetics

Inflammatory Bowel DiseaseGenetic Associations and Epidemiology

Cited by 189

CXCR1‐binding chemokines in inflammatory bowel diseases: down‐regulated IL‐8/CXCL8 production by leukocytes in Crohn's disease and selective GCP‐2/CXCL6 expression in inflamed intestinal tissue

Gijsbers, K., Van Assche, G., Joossens, S., Struyf, S., Proost, P., Rutgeerts, P., Geboes, K., & Van Damme, J. (2004) · European Journal of Immunology

Inflammatory Bowel DiseaseChemokine receptors and signaling

Cited by 77

Sa1922 Pilot Study on the Safety and Efficacy of Faecal Microbiota Transplantation in Refractory Crohn's Disease

Vermeire, S., Joossens, M., Verbeke, K., Hildebrand, F., Machiels, K., Van den Broeck, K., Van Assche, G., Rutgeerts, P. J., & Raes, J. (2012) · Gastroenterology

Inflammatory Bowel DiseaseGut microbiota and health

Cited by 63

Decreased mucosal sulfide detoxification is related to an impaired butyrate oxidation in ulcerative colitis

De Preter, V., Arijs, I., Windey, K., Vanhove, W., Vermeire, S., Schuit, F., Rutgeerts, P., & Verbeke, K. (2012) · Inflammatory Bowel Diseases

Inflammatory Bowel DiseaseGut microbiota and health

Cited by 49

Difference in Pathomechanism Between Crohn’s Disease and Ulcerative Colitis Revealed by Colon Transcriptome

Yang, L., Tang, S., Baker, S. S., Arijs, I., Liu, W., Alkhouri, R., Lan, P., Baker, R. D., Tang, Z., Ji, G., et al. (2019) · Inflammatory Bowel Diseases

Inflammatory Bowel DiseaseOcular Diseases and Behçet’s Syndrome

Cited by 41

Decreased Mucosal Sulfide Detoxification Capacity in Patients With Crohnʼs Disease

Arijs, I., Vanhove, W., Rutgeerts, P., Schuit, F., Verbeke, K., & De Preter, V. (2013) · Inflammatory Bowel Diseases

Inflammatory Bowel DiseaseGut microbiota and health

Cited by 20